Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arati Sharma

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Haematologica|April 2, 2026
Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemiaUpendarrao Golla, Riya Bhalodia, Charyguly Annageldiyev, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypesB Bishal Paudel, Su-Fern Tan, Todd E Fox, et al.
Cancers|March 29, 2023
Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid LeukemiaKelsey H Fisher-Wellman, Miki Kassai, James T Hagen, et al.
Blood Advances|January 3, 2024
Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypesB Bishal Paudel, Su-Fern Tan, Todd E Fox, et al.
Leukemia|February 3, 2021
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemiaZheng Ge, Chunhua Song, Yali Ding, et al.
Oncotarget|November 9, 2016
Acid ceramidase is upregulated in AML and represents a novel therapeutic targetSu-Fern Tan, Xin Liu, Todd E Fox, et al.
Blood Neoplasia|April 17, 2026
Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemiaJohnson Ung, Su-Fern Tan, Jeremy J P Shaw, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia via a cytotoxic integrated stress responseJohnson Ung, Su-Fern Tan, Jeremy J P Shaw, et al.
Blood Advances|September 7, 2019
Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemiaBrian M Barth, Weiyuan Wang, Paul T Toran, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Haematologica|April 2, 2026
Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemiaUpendarrao Golla, Riya Bhalodia, Charyguly Annageldiyev, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypesB Bishal Paudel, Su-Fern Tan, Todd E Fox, et al.
Cancers|March 29, 2023
Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid LeukemiaKelsey H Fisher-Wellman, Miki Kassai, James T Hagen, et al.
Blood Advances|January 3, 2024
Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypesB Bishal Paudel, Su-Fern Tan, Todd E Fox, et al.
Leukemia|February 3, 2021
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemiaZheng Ge, Chunhua Song, Yali Ding, et al.
Oncotarget|November 9, 2016
Acid ceramidase is upregulated in AML and represents a novel therapeutic targetSu-Fern Tan, Xin Liu, Todd E Fox, et al.
Blood Neoplasia|April 17, 2026
Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemiaJohnson Ung, Su-Fern Tan, Jeremy J P Shaw, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia via a cytotoxic integrated stress responseJohnson Ung, Su-Fern Tan, Jeremy J P Shaw, et al.
Blood Advances|September 7, 2019
Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemiaBrian M Barth, Weiyuan Wang, Paul T Toran, et al.
Pageof 9